CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
-16.97%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$9.02B
AUM Growth
-$307M
(-3.3%)
Cap. Flow
-$262M
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
20.75%
Holding
813
New
30
Increased
168
Reduced
3
Closed
20
Top Buys
| 1 |
Hilton Worldwide
HLT
|
$21.1M |
| 2 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$3.53M |
| 3 |
Invesco
IVZ
|
$1.52M |
| 4 |
Sony
SONY
|
$607K |
| 5 |
Microsoft
MSFT
|
$13K |
Top Sells
| 1 |
JD.com
JD
|
$27.3M |
| 2 |
MDCO
Medicines Co
MDCO
|
$13.3M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$12.5M |
| 4 |
Hewlett Packard
HPE
|
$11.3M |
| 5 |
INST
Instructure, Inc.
INST
|
$9.03M |
Sector Composition
| 1 | Healthcare | 30.92% |
| 2 | Technology | 19.77% |
| 3 | Financials | 10.21% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Communication Services | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
McDonald's
MCD
$224B
| $17M | 0.19% |
88,237
| – | – |
|
127
Becton Dickinson
BDX
$55.1B
| $16.8M | 0.19% |
64,788
| – | – |
|
128
Southwest Airlines
LUV
$16.5B
| $16.5M | 0.18% |
312,415
| – | – |
|
129
Jones Lang LaSalle
JLL
$14.8B
| $16.1M | 0.18% |
94,647
| – | – |
|
130
Heron Therapeutics
HRTX
$201M
| $16.1M | 0.18% |
700,510
| – | – |
|
131
Mondelez International
MDLZ
$79.9B
| $16M | 0.18% |
296,961
+53
| +0% | +$2.85K |
|
132
HCA Healthcare
HCA
$98.5B
| $15.9M | 0.18% |
110,009
| – | – |
|
133
NetEase
NTES
$85B
| $15.9M | 0.18% |
264,625
| – | – |
|
134
Karyopharm Therapeutics
KPTI
$57.2M
| $15.8M | 0.18% |
56,358
+2
| +0% | +$562 |
|
|
AERI
135
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $15.8M | 0.18% |
669,800
| – | – |
|
136
Netflix
NFLX
$529B
| $15.7M | 0.17% |
49,786
+1
| +0% | +$316 |
|
137
Newmont
NEM
$83.7B
| $15.6M | 0.17% |
368,387
| – | – |
|
138
Morgan Stanley
MS
$236B
| $15.6M | 0.17% |
311,343
+73
| +0% | +$3.65K |
|
139
Elevance Health
ELV
$70.6B
| $15.6M | 0.17% |
52,681
| – | – |
|
140
Kinder Morgan
KMI
$59.1B
| $15.5M | 0.17% |
750,973
| – | – |
|
141
3M
MMM
$82.7B
| $15.5M | 0.17% |
107,279
| – | – |
|
142
Ionis Pharmaceuticals
IONS
$9.76B
| $15.5M | 0.17% |
261,700
| – | – |
|
143
Fortive
FTV
$16.2B
| $15.4M | 0.17% |
245,639
| – | – |
|
144
Ascendis Pharma
ASND
$12.5B
| $15.2M | 0.17% |
112,000
| – | – |
|
145
New Oriental
EDU
$7.98B
| $15M | 0.17% |
126,600
| – | – |
|
146
Honeywell
HON
$136B
| $14.7M | 0.16% |
85,237
| – | – |
|
147
Eagle Materials
EXP
$7.86B
| $14.6M | 0.16% |
164,566
+19
| +0% | +$1.68K |
|
148
Cigna
CI
$81.5B
| $14.4M | 0.16% |
72,059
+4
| +0% | +$800 |
|
149
Capital One
COF
$142B
| $14.4M | 0.16% |
143,022
+39
| +0% | +$3.92K |
|
150
Consolidated Edison
ED
$35.4B
| $14.3M | 0.16% |
161,243
| – | – |
|